Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

Greenberg, Lauren; Ryom, Lene; Neesgaard, Bastian; Wandeler, Gilles; Staub, Therese; Gisinger, Martin; Skoll, Michael; Günthard, Huldrych F; Scherrer, Alexandra; Mussini, Cristina; Smith, Colette; Johnson, Margaret; De Wit, Stéphane; Necsoi, Coca; Pradier, Christian; Wit, Ferdinand; Lehmann, Clara; D'Arminio Monforte, Antonella; Miró, Jose M; Castagna, Antonella; Spagnuolo, Vincenzo; Sönnerborg, Anders; Law, Matthew; Hutchinson, Jolie; Chkhartishvili, Nikoloz; Bolokadze, Natalia; Wasmuth, Jan-Christian; Stephan, Christoph; Vannappagari, Vani; Rogatto, Felipe; Llibre, Josep M; Duvivier, Claudine; Hoy, Jennifer; Bloch, Mark; Bucher, Heiner C; Calmy, Alexandra; Volny Anne, Alain; Pelchen-Matthews, Annegret; Lundgren, Jens D; Peters, Lars; Bansi-Matharu, Loveleen; Mocroft, Amanda

doi:10.1093/cid/ciaa1878

Limited data exist comparing clinical outcomes of two-drug regimens (2DRs) and three-drug regimens (3DRs) in people living with HIV.

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV / Greenberg, L., Ryom, L., Neesgaard, B., Wandeler, G., Staub, T., Gisinger, M., Skoll, M., Günthard, H.F., Scherrer, A., Mussini, C., Smith, C., Johnson, M., De Wit, S., Necsoi, C., Pradier, C., Wit, F., Lehmann, C., D'Arminio Monforte, A., Miró, J.M., Castagna, A., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 73:7(2021), pp. 2323-2333. [10.1093/cid/ciaa1878]